nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Cefaclor—Dysuria—Methotrexate—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Cefaclor—Neutropenia—Methotrexate—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Cefaclor—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Cefaclor—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Cefaclor—Shock—Prednisolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Cefaclor—Cough—Triamcinolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Cefaclor—Convulsion—Triamcinolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Cefaclor—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Cefaclor—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Cefaclor—Myalgia—Triamcinolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Cefaclor—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Cefaclor—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Cefaclor—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Cefaclor—Infestation NOS—Methotrexate—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Cefaclor—Infestation—Methotrexate—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Cefaclor—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Cefaclor—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Cefaclor—Discomfort—Triamcinolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Cefaclor—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Cefaclor—Angioedema—Betamethasone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Cefaclor—Angioedema—Dexamethasone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Cefaclor—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Cefaclor—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Cefaclor—Immune system disorder—Prednisone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Cefaclor—Malaise—Dexamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Cefaclor—Malaise—Betamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Cefaclor—Oedema—Triamcinolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Cefaclor—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Cefaclor—Vertigo—Dexamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Cefaclor—Vertigo—Betamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Cefaclor—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Cefaclor—Syncope—Dexamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Cefaclor—Syncope—Betamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Cefaclor—Sweating—Methotrexate—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Cefaclor—Haematuria—Methotrexate—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Cefaclor—Shock—Triamcinolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Cefaclor—Insomnia—Prednisolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Cefaclor—Shock—Methylprednisolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Cefaclor—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Cefaclor—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Cefaclor—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Cefaclor—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Cefaclor—Epistaxis—Methotrexate—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Cefaclor—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Cefaclor—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Cefaclor—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Cefaclor—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Cefaclor—Convulsion—Dexamethasone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Cefaclor—Convulsion—Betamethasone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Cefaclor—Myalgia—Dexamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Cefaclor—Myalgia—Betamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Cefaclor—Anxiety—Dexamethasone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Cefaclor—Anxiety—Betamethasone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Cefaclor—Discomfort—Betamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Cefaclor—Discomfort—Dexamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Cefaclor—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Cefaclor—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefaclor—Pain—Prednisolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefaclor—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefaclor—Hepatitis—Methotrexate—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefaclor—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Cefaclor—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Cefaclor—Oedema—Dexamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Cefaclor—Oedema—Betamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Cefaclor—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Cefaclor—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Cefaclor—Insomnia—Triamcinolone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Cefaclor—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Cefaclor—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Cefaclor—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Cefaclor—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cefaclor—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cefaclor—Shock—Betamethasone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cefaclor—Shock—Dexamethasone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cefaclor—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Cefaclor—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Cefaclor—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Cefaclor—Agitation—Prednisone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Cefaclor—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Cefaclor—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Cefaclor—Angioedema—Prednisone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Cefaclor—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Cefaclor—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Cefaclor—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Cefaclor—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Cefaclor—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Cefaclor—Malaise—Prednisone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Cefaclor—Vertigo—Prednisone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Cefaclor—Syncope—Prednisone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Cefaclor—Anorexia—Dexamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Cefaclor—Anorexia—Betamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Cefaclor—Urticaria—Prednisolone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Cefaclor—Pain—Triamcinolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Cefaclor—Loss of consciousness—Prednisone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cefaclor—Hypotension—Betamethasone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Cefaclor—Hypotension—Dexamethasone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Cefaclor—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Cefaclor—Convulsion—Prednisone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Cefaclor—Chills—Methotrexate—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Cefaclor—Arthralgia—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Cefaclor—Myalgia—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Cefaclor—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Cefaclor—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Cefaclor—Anxiety—Prednisone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Cefaclor—Insomnia—Dexamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Cefaclor—Insomnia—Betamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Cefaclor—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Cefaclor—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Cefaclor—Paraesthesia—Betamethasone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Cefaclor—Discomfort—Prednisone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Cefaclor—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Cefaclor—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Cefaclor—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Cefaclor—Urticaria—Triamcinolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Cefaclor—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefaclor—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefaclor—Oedema—Prednisone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefaclor—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefaclor—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Cefaclor—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Cefaclor—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Cefaclor—Back pain—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Cefaclor—Shock—Prednisone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Cefaclor—Pain—Betamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Cefaclor—Pain—Dexamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Cefaclor—Nervous system disorder—Prednisone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Cefaclor—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Cefaclor—Anorexia—Prednisone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Cefaclor—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Cefaclor—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Cefaclor—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Cefaclor—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Cefaclor—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Cefaclor—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Cefaclor—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Cefaclor—Malaise—Methotrexate—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Cefaclor—Vertigo—Methotrexate—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Cefaclor—Leukopenia—Methotrexate—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Cefaclor—Urticaria—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefaclor—Urticaria—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefaclor—Dizziness—Prednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefaclor—Asthenia—Triamcinolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Cefaclor—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Cefaclor—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Cefaclor—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Cefaclor—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Cefaclor—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Cefaclor—Insomnia—Prednisone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Cefaclor—Paraesthesia—Prednisone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Cefaclor—Pruritus—Triamcinolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Cefaclor—Cough—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Cefaclor—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Cefaclor—Convulsion—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Cefaclor—Dyspepsia—Prednisone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Cefaclor—Chest pain—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Cefaclor—Myalgia—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Cefaclor—Arthralgia—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Cefaclor—Decreased appetite—Prednisone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Cefaclor—Rash—Prednisolone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Cefaclor—Dermatitis—Prednisolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Cefaclor—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Cefaclor—Headache—Prednisolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Cefaclor—Discomfort—Methotrexate—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Cefaclor—Constipation—Prednisone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Cefaclor—Confusional state—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Cefaclor—Dizziness—Triamcinolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Cefaclor—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Cefaclor—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Cefaclor—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Cefaclor—Asthenia—Dexamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Cefaclor—Asthenia—Betamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Cefaclor—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Cefaclor—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Cefaclor—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Cefaclor—Nausea—Prednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Cefaclor—Pruritus—Betamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Cefaclor—Pruritus—Dexamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Cefaclor—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Cefaclor—Vomiting—Triamcinolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefaclor—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefaclor—Rash—Triamcinolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Cefaclor—Dermatitis—Triamcinolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefaclor—Anorexia—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefaclor—Rash—Methylprednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefaclor—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefaclor—Urticaria—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefaclor—Headache—Triamcinolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefaclor—Headache—Methylprednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Cefaclor—Abdominal pain—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Cefaclor—Body temperature increased—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Cefaclor—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Cefaclor—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Cefaclor—Hypotension—Methotrexate—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Cefaclor—Dizziness—Betamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Cefaclor—Dizziness—Dexamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Cefaclor—Insomnia—Methotrexate—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Cefaclor—Nausea—Triamcinolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Cefaclor—Paraesthesia—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Cefaclor—Nausea—Methylprednisolone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Cefaclor—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Cefaclor—Somnolence—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Cefaclor—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Cefaclor—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Cefaclor—Vomiting—Dexamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Cefaclor—Vomiting—Betamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Cefaclor—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefaclor—Rash—Dexamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefaclor—Rash—Betamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefaclor—Dermatitis—Betamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefaclor—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Cefaclor—Headache—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Cefaclor—Headache—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Cefaclor—Asthenia—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Cefaclor—Pain—Methotrexate—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Cefaclor—Pruritus—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Cefaclor—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Cefaclor—Diarrhoea—Prednisone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Cefaclor—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Cefaclor—Nausea—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Cefaclor—Nausea—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Cefaclor—Urticaria—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Cefaclor—Dizziness—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Cefaclor—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Cefaclor—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Cefaclor—Vomiting—Prednisone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Cefaclor—Rash—Prednisone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Cefaclor—Dermatitis—Prednisone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Cefaclor—Headache—Prednisone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Cefaclor—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Cefaclor—Asthenia—Methotrexate—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Cefaclor—Nausea—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Cefaclor—Pruritus—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Cefaclor—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Cefaclor—Dizziness—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Cefaclor—Vomiting—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Cefaclor—Rash—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Cefaclor—Dermatitis—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Cefaclor—Headache—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Cefaclor—Nausea—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
